Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: PTO statistics (through March 31, 2006)

key words:

 The reexamination process, particularly for third parties, offers no realistic alternative to a court action to challenge a patent and is heavily weighted in favor of the patent holder through the denial of participation to the third party in the reexamination. 

 

 

Share
New Message
Please login to post a reply